This video was recorded during the LiveLung Small Cell Lung Cancer Summit - April 18-19, 2023
About the Speaker
Triparna Sen, PhD, MS
Associate Professor and Medical Researcher
Icahn School of Medicine at Mount Sinai
Dr Triparna Sen is an Associate Professor, in the Department of Oncological Sciences, and the Co-Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, New York. The Sen lab focuses on the development of new treatment paradigms for clinically relevant molecular subsets of lung cancer, using genetic and transcriptomic analyses; functional genomics; and patient-derived models of lung cancer. As the Co-Director of the Lung Cancer PDX program at Mount Sinai, which will acquire human samples from the clinic for the development of cancer models and assess experimental cancer therapeutics in the preclinical setting.
Previously, Dr Sen identified that DNA damage response (DDR) proteins are effective therapeutic targets for small cell lung cancer treatment and that targeting DDR promotes antitumor immunity through activation of innate immune signaling. In her recent work, Dr. Sen identified molecular determinants and novel therapeutic targets for lineage plasticity in lung cancer.
Dr Sen has received several prestigious awards including- AAAS Martin and Rose Wachtel Cancer Research Award (2021); 40 under 40 in Cancer- Emerging Leaders Award (2020); AACR Women in Cancer Research Scholar Award; AACR Scholar-in-training award; Jeffrey Lee Cousins fellowship and Immuno-Oncology-Young Investigator award. Dr. Sen is invited to deliver talks and educational sessions at major national and international meetings. Dr. Sen has received independent grant funding from the National Institute of Health (NIH/NCI-R01), Department of Defense (DoD) Lung Cancer Research Program, Lung Cancer Research Foundation (LCRF), and The International Association for the Study of Lung Cancer (IASLC). She is the author of several peer-reviewed scientific manuscripts, and she is an active member of the IASLC, and the American Association for Cancer Research (AACR). She has authored over 45 peer-reviewed scientific manuscripts in high-impact journals. Due to her expertise and contribution, she has been nominated to be the Conference Co-Chair of the Hot Topic: Small Cell Lung Cancer (SCLC) Meeting supported by the International Association for the Study of Lung Cancer (IASLC, October 2021).
The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical.
This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.
LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.